InMed Pharmaceuticals (INM) Institutional Ownership → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free INM Stock Alerts $0.23 -0.02 (-8.00%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for InMed Pharmaceuticals (NASDAQ:INM)CurrentInstitutional OwnershipPercentage20.12%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$85.68KNumber ofInstitutional Sellers(last 12 months)0 Get INM Insider Trade Alerts Want to know when executives and insiders are buying or selling InMed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INM Institutional Buying and Selling by Quarter Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> InMed Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC205,968$86K0.0%N/A3.916% 11/14/2022Armistice Capital LLC90,000$593K0.0%-90.6%9.605% 5/17/2022Empery Asset Management LP61,741$58K0.3%N/A0.437% 8/17/2021Armistice Capital LLC890,000$2.83M0.1%+278.7%9.954% 8/12/2021Penserra Capital Management LLC19,912$49K0.0%N/A0.223% 5/21/2021Citadel Advisors LLC17,211$57K0.0%N/A0.214% 5/18/2021Citadel Advisors LLC17,211$57K0.0%N/A0.214% 5/17/2021Armistice Capital LLC235,000$776K0.0%N/A2.919% 1/29/2021Creative Planning10,990$36K0.0%N/A0.157% (Data available from 1/1/2016 forward) INM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INM shares? During the previous two years, the following institutional investors and hedge funds held shares of InMed Pharmaceuticals shares: Armistice Capital LLC ($86K), Empery Asset Management LP ($58K).Learn more on INM's institutional investors. What percentage of InMed Pharmaceuticals stock is owned by institutional investors? 20.12% of InMed Pharmaceuticals stock is owned by institutional investors. Learn more on INM's institutional investor holdings. Which institutional investors have been buying InMed Pharmaceuticals stock? The following institutional investors have purchased InMed Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($205.97K), and Empery Asset Management LP ($61.74K). How much institutional buying is happening at InMed Pharmaceuticals? Institutional investors have bought a total of 267,709 shares in the last 24 months. This purchase volume represents approximately $1.54M in transactions. Which InMed Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold InMed Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($866.12K). How much institutional selling is happening at InMed Pharmaceuticals? Institutional investors have sold a total of 866,118 shares in the last 24 months. This volume of shares sold represents approximately $5.71M in transactions. Related Companies: DRMA Major Shareholders PBLA Major Shareholders QLGN Major Shareholders LSDI Major Shareholders GLMD Major Shareholders CMND Major Shareholders SLRX Major Shareholders NBSE Major Shareholders NTBL Major Shareholders CNSP Major Shareholders This page (NASDAQ:INM) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
